589 related articles for article (PubMed ID: 18565887)
1. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.
Murat A; Migliavacca E; Gorlia T; Lambiv WL; Shay T; Hamou MF; de Tribolet N; Regli L; Wick W; Kouwenhoven MC; Hainfellner JA; Heppner FL; Dietrich PY; Zimmer Y; Cairncross JG; Janzer RC; Domany E; Delorenzi M; Stupp R; Hegi ME
J Clin Oncol; 2008 Jun; 26(18):3015-24. PubMed ID: 18565887
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.
Metellus P; Nanni-Metellus I; Delfino C; Colin C; Tchogandjian A; Coulibaly B; Fina F; Loundou A; Barrie M; Chinot O; Ouafik L; Figarella-Branger D
Ann Surg Oncol; 2011 Oct; 18(10):2937-45. PubMed ID: 21479688
[TBL] [Abstract][Full Text] [Related]
3. Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy.
Weller M; Kaulich K; Hentschel B; Felsberg J; Gramatzki D; Pietsch T; Simon M; Westphal M; Schackert G; Tonn JC; von Deimling A; Davis T; Weiss WA; Loeffler M; Reifenberger G;
Int J Cancer; 2014 May; 134(10):2437-47. PubMed ID: 24614983
[TBL] [Abstract][Full Text] [Related]
4. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
[TBL] [Abstract][Full Text] [Related]
5. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
Brandes AA; Franceschi E; Tosoni A; Blatt V; Pession A; Tallini G; Bertorelle R; Bartolini S; Calbucci F; Andreoli A; Frezza G; Leonardi M; Spagnolli F; Ermani M
J Clin Oncol; 2008 May; 26(13):2192-7. PubMed ID: 18445844
[TBL] [Abstract][Full Text] [Related]
6. Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.
Hegi ME; Janzer RC; Lambiv WL; Gorlia T; Kouwenhoven MC; Hartmann C; von Deimling A; Martinet D; Besuchet Schmutz N; Diserens AC; Hamou MF; Bady P; Weller M; van den Bent MJ; Mason WP; Mirimanoff RO; Stupp R; Mokhtari K; Wesseling P; ;
Acta Neuropathol; 2012 Jun; 123(6):841-52. PubMed ID: 22249618
[TBL] [Abstract][Full Text] [Related]
7. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.
Gorlia T; van den Bent MJ; Hegi ME; Mirimanoff RO; Weller M; Cairncross JG; Eisenhauer E; Belanger K; Brandes AA; Allgeier A; Lacombe D; Stupp R
Lancet Oncol; 2008 Jan; 9(1):29-38. PubMed ID: 18082451
[TBL] [Abstract][Full Text] [Related]
8. MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature.
Gaspar N; Marshall L; Perryman L; Bax DA; Little SE; Viana-Pereira M; Sharp SY; Vassal G; Pearson AD; Reis RM; Hargrave D; Workman P; Jones C
Cancer Res; 2010 Nov; 70(22):9243-52. PubMed ID: 20935218
[TBL] [Abstract][Full Text] [Related]
9. Epidermal Growth Factor Receptor Expression Predicts Time and Patterns of Recurrence in Patients with Glioblastoma After Radiotherapy and Temozolomide.
Tini P; Nardone V; Pastina P; Battaglia G; Miracco C; Carbone SF; Sebaste L; Rubino G; Cerase A; Pirtoli L
World Neurosurg; 2018 Jan; 109():e662-e668. PubMed ID: 29061455
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disease: temozolomide and glioblastoma--look to the future.
Mrugala MM; Chamberlain MC
Nat Clin Pract Oncol; 2008 Aug; 5(8):476-86. PubMed ID: 18542116
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
[TBL] [Abstract][Full Text] [Related]
12. Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death.
Wasserfallen JB; Ostermann S; Pica A; Mirimanoff RO; Leyvraz S; Villemure JG; Stupp R
Cancer; 2004 Nov; 101(9):2098-105. PubMed ID: 15389472
[TBL] [Abstract][Full Text] [Related]
13. Predictive biomarkers investigated in glioblastoma.
Tabouret E; Chinot O; Sanson M; Loundou A; Hoang-Xuan K; Delattre JY; Idbaih A
Expert Rev Mol Diagn; 2014 Sep; 14(7):883-93. PubMed ID: 25096963
[TBL] [Abstract][Full Text] [Related]
14. Problems of Glioblastoma Multiforme Drug Resistance.
Stavrovskaya AA; Shushanov SS; Rybalkina EY
Biochemistry (Mosc); 2016 Feb; 81(2):91-100. PubMed ID: 27260389
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.
Abhinav K; Aquilina K; Gbejuade H; La M; Hopkins K; Iyer V
Clin Neurol Neurosurg; 2013 Aug; 115(8):1375-8. PubMed ID: 23333005
[TBL] [Abstract][Full Text] [Related]
16. Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.
Schmid RS; Simon JM; Vitucci M; McNeill RS; Bash RE; Werneke AM; Huey L; White KK; Ewend MG; Wu J; Miller CR
Neuro Oncol; 2016 Jul; 18(7):962-73. PubMed ID: 26826202
[TBL] [Abstract][Full Text] [Related]
17. [Glioblastoma in the elderly].
Delattre JY
Rev Neurol (Paris); 2011 Oct; 167(10):680-2. PubMed ID: 21890157
[TBL] [Abstract][Full Text] [Related]
18. Identification of a DNA Repair-Related Multigene Signature as a Novel Prognostic Predictor of Glioblastoma.
Jin S; Qian Z; Liang T; Liang J; Yang F; Sun L; Li W; Qiu X; Zhang M
World Neurosurg; 2018 Sep; 117():e34-e41. PubMed ID: 29807183
[TBL] [Abstract][Full Text] [Related]
19. The radiosensitivity index predicts for overall survival in glioblastoma.
Ahmed KA; Chinnaiyan P; Fulp WJ; Eschrich S; Torres-Roca JF; Caudell JJ
Oncotarget; 2015 Oct; 6(33):34414-22. PubMed ID: 26451615
[TBL] [Abstract][Full Text] [Related]
20. Elderly patients with glioblastoma: the treatment challenge.
Fiorentino A; De Bonis P; Chiesa S; Balducci M; Fusco V
Expert Rev Neurother; 2013 Oct; 13(10):1099-105. PubMed ID: 24117272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
